| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/24/1996 | CN1127257A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127256A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127140A Cosmetic and skin-usefull composition containing water from hot spring, mineral water and agent against acne and oldening |
| 07/24/1996 | CN1127116A New composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effec |
| 07/23/1996 | US5538969 4-amino derivatives of 5-substituted mycophenolic acid |
| 07/23/1996 | US5538945 Stimulation of hair growth by peptide copper complexes |
| 07/23/1996 | US5538731 Plant extract from solvent extraction as enzyme inhibitors for skin depigmentation |
| 07/23/1996 | CA1338484C 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996008569A3 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/18/1996 | CA2735293A1 Nadh and nadph therapeutic agents for dermal administration |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/17/1996 | EP0721779A2 Combination of active agents, against superinfections, containing a mixture of wool wax acids and alpha-omega alkanoic dicarboxylic acids |
| 07/17/1996 | EP0721775A2 Combination of active agents efficcient against unhealthy skin, mild acne and grampositive bacteria |
| 07/17/1996 | EP0721457A1 2',5'-OLIGOADENYLATE-2',3'-CYCLOPHOSPHATES and 2',5'-OLIGOADENYLATES with antipapilloma virus activity |
| 07/17/1996 | EP0721349A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
| 07/17/1996 | EP0721348A1 Monoglyceride/lactate ester permeation enhancer |
| 07/17/1996 | EP0721347A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections |
| 07/17/1996 | EP0721335A1 Mycophenolate mofetil high dose oral suspensions |
| 07/17/1996 | CN1126995A Antiallergic imidazoazepines |
| 07/16/1996 | US5536752 Phenyl heterocycles as COX-2 inhibitors |
| 07/16/1996 | US5536747 Enzyme inhibitors |
| 07/16/1996 | US5536740 Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester |
| 07/11/1996 | WO1996021037A1 Arachidonic acid and methods for the production and use thereof |
| 07/11/1996 | WO1996021000A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 07/11/1996 | WO1996020936A1 Novel thiazolidin-4-one derivatives |
| 07/11/1996 | WO1996020918A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | WO1996020914A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | WO1996020710A1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/11/1996 | WO1996020703A1 Compounds for veterinary and medicinal applications |
| 07/11/1996 | WO1996020701A1 Apoptosis-modulating composition comprising a factor affecting the intracellular rate of methional or malondialdehyde |
| 07/11/1996 | CA2209134A1 Tricyclic retinoids, methods for their production and use |
| 07/11/1996 | CA2208679A1 Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 07/11/1996 | CA2208580A1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/11/1996 | CA2184174A1 Novel thiazolidin-4-one derivatives |
| 07/10/1996 | EP0720853A1 Topical administrable zinc phtalocyanine compositions |
| 07/10/1996 | EP0720847A1 Cosmetic or dermatological composition containing at least one ceramide 6 |
| 07/10/1996 | EP0720481A1 Uses of vegetable oils |
| 07/10/1996 | EP0720475A1 Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine for the treatment of alzheimer's disease |
| 07/10/1996 | CN1126468A Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 07/10/1996 | CN1126203A Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| 07/09/1996 | US5534539 Antitumor agents |
| 07/09/1996 | CA2099381C Imidazopyridine paf/h _antagonists |
| 07/06/1996 | CA2166527A1 Topical pharmaceutical compositions |
| 07/04/1996 | WO1996020284A1 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
| 07/04/1996 | WO1996020215A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
| 07/04/1996 | WO1996020200A1 6-[triazolyl[3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones |
| 07/04/1996 | WO1996020193A1 Compounds and methods |
| 07/04/1996 | WO1996020184A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 07/04/1996 | WO1996020000A1 Cosmetic or pharmaceutical and particularly dermatological composition, and culture medium containing a smelophyllum capense extract |
| 07/04/1996 | CA2208706A1 Mutants of the rb and p53 genes and uses thereof |
| 07/04/1996 | CA2208233A1 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
| 07/04/1996 | CA2207772A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 07/04/1996 | CA2207268A1 6-¬triazolyl¬3-(trifluoromethyl)phenyl¦methyl¦-2-quinolinones and -quinolinethiones |
| 07/03/1996 | EP0719770A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 07/03/1996 | EP0719538A1 Skin external agent |
| 07/03/1996 | EP0719331A1 Eotaxin = eosinophil chemotactic cytokine |
| 07/03/1996 | EP0719150A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 07/03/1996 | EP0719145A1 Nitric oxide donor composition and method for treatment of anal disorders |
| 07/03/1996 | EP0719137A1 Viscous surfactant emulsion compositions |
| 07/03/1996 | CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 07/03/1996 | CN1125941A Novel vitamin D analogues |
| 07/03/1996 | CN1125598A Medicine for treatment of wart and its compounding method |
| 07/03/1996 | CN1032204C Process for preparing acetylenes disubstituted with phenyl group and heterobicyclic group having retinoid like activity |
| 07/02/1996 | US5532343 Purification and characterization of a glioma-derived growth factor having vascular endothelial cell growth promoting activity |
| 07/02/1996 | US5532248 O-aryl,O-alkyl, and O-alkenyl-macrolides having immunosuppressive activity |
| 07/02/1996 | US5532233 Platelet activating factor antagonist |
| 07/02/1996 | US5532227 Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive glycosylation of different types of collagen and other proteins during diabetes |
| 07/02/1996 | US5532152 Platelet-activating factor acetylhydrolase |
| 07/02/1996 | US5531992 Antiinflammatory |
| 07/02/1996 | CA2078347C Use of copper(ii) containing compounds to accelerate wound healing |
| 06/29/1996 | CA2166168A1 Esculetin derivatives, method for manufacture thereof, and pharmaceutical composition |
| 06/27/1996 | WO1996019233A2 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 06/27/1996 | WO1996019228A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | WO1996019204A1 Medicated tissue paper product |
| 06/27/1996 | WO1996019186A1 Antifungal treatment of nails |
| 06/27/1996 | WO1996019183A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | CA2208268A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | CA2208088A1 Antifungal treatment of nails |
| 06/26/1996 | EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies |
| 06/26/1996 | EP0717997A1 Use of substance P antagonist in pharmaceutical composition |
| 06/26/1996 | EP0717994A1 New formulation for the topical treatment of psoriasis |
| 06/26/1996 | EP0717985A1 Dermatologic preparation |
| 06/26/1996 | EP0717984A2 Lactate dehydrogenase inhibitors in cosmetic compositions |
| 06/26/1996 | EP0717983A1 Cosmetic compositions containing betulinic acid |
| 06/26/1996 | EP0696201A4 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 06/26/1996 | CN1125444A Antiproliferative naphthyridines |
| 06/26/1996 | CN1125442A Imidazole lipoxygenase inhibitors |
| 06/26/1996 | CN1125436A Vitamin D amide derivatives |
| 06/26/1996 | CN1125139A Antiphlogistic analgesic ointment for treating burn |
| 06/26/1996 | CN1125117A Ointment for curing eczema |
| 06/26/1996 | CN1125093A High effective multifunctional face beautifying cream and preparing method thereof |
| 06/25/1996 | US5530109 DNA encoding glial mitogenic factors |
| 06/25/1996 | US5530102 Methods and compositions for the direct concentrated delivery of passive immunity |
| 06/25/1996 | US5530019 For treatment of prostate gland disorders |
| 06/25/1996 | US5529991 Oral 1α-hydroxyprevitamin D |
| 06/25/1996 | US5529770 Viscous liquid conditioning topical germicides |
| 06/25/1996 | US5529769 Cosmetic compositions containing betulinic acid |
| 06/25/1996 | CA2034934C Transdermal therapeutic system comprising tulobuterol as active substance |